Documents
Application Sponsors
Marketing Status
Application Products
001 | SPRAY, METERED;NASAL | 0.05MG/SPRAY | 0 | ALLERNAZE | TRIAMCINOLONE ACETONIDE |
FDA Submissions
TYPE 3; Type 3 - New Dosage Form | ORIG | 1 | AP | 2000-02-04 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 2 | AP | 2009-01-07 | N/A |
Submissions Property Types
CDER Filings
LUPIN ATLANTIS
cder:Array
(
[0] => Array
(
[ApplNo] => 20120
[companyName] => LUPIN ATLANTIS
[docInserts] => ["",""]
[products] => [{"drugName":"ALLERNAZE","activeIngredients":"TRIAMCINOLONE ACETONIDE","strength":"0.05MG\/SPRAY","dosageForm":"SPRAY, METERED;NASAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] => [{"actionDate":"01\/07\/2009","submission":"SUPPL-2","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2009\\\/020120s002lbl.pdf\"}]","notes":""},{"actionDate":"01\/07\/2009","submission":"SUPPL-2","supplementCategories":"Labeling-Container\/Carton Labels","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2009\\\/020120s002lbl.pdf\"}]","notes":""},{"actionDate":"02\/04\/2000","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2000\\\/20120lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"ALLERNAZE","submission":"TRIAMCINOLONE ACETONIDE","actionType":"0.05MG\/SPRAY","submissionClassification":"SPRAY, METERED;NASAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 2009-01-07
)
)